CIK 0001055726 · Non-accelerated filer<br>Smaller reporting company
INOVIO PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- INO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 330969592
- Phone
- 8584103134
- Business address
- 660 W. GERMANTOWN PIKE, SUITE 110, PLYMOUTH MEETING, PA, 19462
- Former names
- INOVIO BIOMEDICAL CORP, GENETRONICS BIOMEDICAL CORP, GENETRONICS BIOMEDICAL LTD
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-05-15 | Shepard Jay Director | Grant or award · Common Stock Options | +35,000 | 35,000 | ||
| 2023-05-15 | Shepard Jay Director | Grant or award · Restricted Stock Unit | +26,000 | 26,000 | ||
| 2023-05-15 | BENITO SIMON X Director | Grant or award · Common Stock Options | +35,000 | 35,000 | ||
| 2023-05-15 | BENITO SIMON X Director | Grant or award · Restricted Stock Unit | +26,000 | 26,000 | ||
| 2023-05-15 | Miller Ann Calby Director | Grant or award · Common Stock Options | +35,000 | 35,000 | ||
| 2023-05-15 | Miller Ann Calby Director | Grant or award · Restricted Stock Unit | +26,000 | 26,000 | ||
| 2023-05-15 | DANSEY ROGER D Director | Grant or award · Common Stock Options | +35,000 | 35,000 | ||
| 2023-05-15 | DANSEY ROGER D Director | Grant or award · Restricted Stock Unit | +26,000 | 26,000 | ||
| 2023-05-13 | DANSEY ROGER D Director | Option exercise | +12,000 | 24,000 | ||
| 2023-05-13 | DANSEY ROGER D Director | Option exercise · Restricted Stock Unit | −12,000 | 12,000 | ||
| 2023-05-10 | Shea Jacqueline Elizabeth Chief Executive Officer | Option exercise | +66,000 | 226,817 | ||
| 2023-05-10 | Shea Jacqueline Elizabeth Chief Executive Officer | Shares withheld for taxes | −28,704 | $0.81 | $23K | 198,113 |
| 2023-05-10 | Shea Jacqueline Elizabeth Chief Executive Officer | Option exercise · Restricted Stock Unit | −66,000 | 132,000 | ||
| 2023-03-13 | Weiner David B. Director | Sale | −5,833 | $1.15 | $7K | 910,124 |
| 2023-03-11 | Weiner David B. Director | Option exercise | +11,666 | 915,957 | ||
| 2023-03-11 | Weiner David B. Director | Option exercise · Restricted Stock Unit | −11,666 | 0 | ||
| 2023-03-11 | Humeau Laurent Chief Scientific Officer | Option exercise | +59,737 | 235,295 | ||
| 2023-03-11 | Humeau Laurent Chief Scientific Officer | Shares withheld for taxes | −20,658 | $1.13 | $23K | 214,637 |
| 2023-03-11 | Humeau Laurent Chief Scientific Officer | Option exercise · Restricted Stock Unit | −59,737 | 0 | ||
| 2023-03-11 | Shea Jacqueline Elizabeth Chief Executive Officer | Option exercise | +59,737 | 186,797 |
Page 14 of 17 · 322 trades